These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

728 related articles for article (PubMed ID: 24590287)

  • 81. EP300/CBP is crucial for cAMP-PKA pathway to alleviate podocyte dedifferentiation via targeting Notch3 signaling.
    Chang K; Xue R; Zhao M; Zhao Y; Yu W; Zhao Z; Liu X
    Exp Cell Res; 2021 Oct; 407(2):112825. PubMed ID: 34506759
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The PDE5 inhibitor, vardenafil, ameliorates progressive pathological changes in a focal segmental glomerulosclerosis mouse model.
    Hu SW; Wang YH; Huang JS; Yang YM; Wu CC; Cheng CW
    Life Sci; 2022 Nov; 309():120992. PubMed ID: 36155178
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Glomerular endothelial cell injury and focal segmental glomerulosclerosis lesion in idiopathic membranous nephropathy.
    Morita M; Mii A; Shimizu A; Yasuda F; Shoji J; Masuda Y; Ohashi R; Nagahama K; Kaneko T; Tsuruoka S
    PLoS One; 2015; 10(4):e0116700. PubMed ID: 25875837
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Podocytes-The Most Vulnerable Renal Cells in Preeclampsia.
    Kwiatkowska E; Stefańska K; Zieliński M; Sakowska J; Jankowiak M; Trzonkowski P; Marek-Trzonkowska N; Kwiatkowski S
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708979
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Role of podocytes for reversal of glomerulosclerosis and proteinuria in the aging kidney after endothelin inhibition.
    Ortmann J; Amann K; Brandes RP; Kretzler M; Münter K; Parekh N; Traupe T; Lange M; Lattmann T; Barton M
    Hypertension; 2004 Dec; 44(6):974-81. PubMed ID: 15545511
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Podocyte injury and overexpression of vascular endothelial growth factor and transforming growth factor-beta 1 in adriamycin-induced nephropathy in rats.
    Yang W; Wang J; Shi L; Yu L; Qian Y; Liu Y; Wang W; Cheng S
    Cytokine; 2012 Aug; 59(2):370-6. PubMed ID: 22579701
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Paracrine role for TGF-β-induced CTGF and VEGF in mesangial matrix expansion in progressive glomerular disease.
    Lee HS
    Histol Histopathol; 2012 Sep; 27(9):1131-41. PubMed ID: 22806900
    [TBL] [Abstract][Full Text] [Related]  

  • 88. CircZNF609 is involved in the pathogenesis of focal segmental glomerulosclerosis by sponging miR-615-5p.
    Cui X; Fu J; Luan J; Qi H; Jiao C; Ran M; Wang D; Hao X; Zhang Y; Kopp JB; Pi J; Zhou H
    Biochem Biophys Res Commun; 2020 Oct; 531(3):341-349. PubMed ID: 32800553
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Partial podocyte replenishment in experimental FSGS derives from nonpodocyte sources.
    Kaverina NV; Eng DG; Schneider RR; Pippin JW; Shankland SJ
    Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1397-413. PubMed ID: 27076646
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Loss of the podocyte-expressed transcription factor Tcf21/Pod1 results in podocyte differentiation defects and FSGS.
    Maezawa Y; Onay T; Scott RP; Keir LS; Dimke H; Li C; Eremina V; Maezawa Y; Jeansson M; Shan J; Binnie M; Lewin M; Ghosh A; Miner JH; Vainio SJ; Quaggin SE
    J Am Soc Nephrol; 2014 Nov; 25(11):2459-70. PubMed ID: 24904088
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Colony stimulating factor-1 receptor drives glomerular parietal epithelial cell activation in focal segmental glomerulosclerosis.
    Cruzado JM; Manonelles A; Rayego-Mateos S; Doladé N; Amaya-Garrido A; Varela C; Guiteras R; Mosquera JL; Jung M; Codina S; Martínez-Valenzuela L; Draibe J; Couceiro C; Vigués F; Madrid Á; Florian MC; Ruíz-Ortega M; Sola A
    Kidney Int; 2024 Jul; 106(1):67-84. PubMed ID: 38428734
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Krüppel-like factor 6 regulates mitochondrial function in the kidney.
    Mallipattu SK; Horne SJ; D'Agati V; Narla G; Liu R; Frohman MA; Dickman K; Chen EY; Ma'ayan A; Bialkowska AB; Ghaleb AM; Nandan MO; Jain MK; Daehn I; Chuang PY; Yang VW; He JC
    J Clin Invest; 2015 Mar; 125(3):1347-61. PubMed ID: 25689250
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Apoptosis in podocytes induced by TGF-beta and Smad7.
    Schiffer M; Bitzer M; Roberts IS; Kopp JB; ten Dijke P; Mundel P; Böttinger EP
    J Clin Invest; 2001 Sep; 108(6):807-16. PubMed ID: 11560950
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Discovery of new glomerular disease-relevant genes by translational profiling of podocytes in vivo.
    Grgic I; Hofmeister AF; Genovese G; Bernhardy AJ; Sun H; Maarouf OH; Bijol V; Pollak MR; Humphreys BD
    Kidney Int; 2014 Dec; 86(6):1116-29. PubMed ID: 24940801
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease.
    Krall P; Canales CP; Kairath P; Carmona-Mora P; Molina J; Carpio JD; Ruiz P; Mezzano SA; Li J; Wei C; Reiser J; Young JI; Walz K
    PLoS One; 2010 Sep; 5(9):e12859. PubMed ID: 20877463
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Secondary Focal Segmental Glomerulosclerosis: From Podocyte Injury to Glomerulosclerosis.
    Kim JS; Han BG; Choi SO; Cha SK
    Biomed Res Int; 2016; 2016():1630365. PubMed ID: 27088082
    [TBL] [Abstract][Full Text] [Related]  

  • 97. In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease.
    da Silva CA; Monteiro MLGDR; Araújo LS; Urzedo MG; Rocha LB; Dos Reis MA; Machado JR
    PLoS One; 2020; 15(11):e0241745. PubMed ID: 33147279
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Activation of necroptosis pathway in podocyte contributes to the pathogenesis of focal segmental glomerular sclerosis.
    Hu H; Li M; Chen B; Guo C; Yang N
    Clin Exp Nephrol; 2022 Nov; 26(11):1055-1066. PubMed ID: 35925422
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Up-regulation of the homophilic adhesion molecule sidekick-1 in podocytes contributes to glomerulosclerosis.
    Kaufman L; Potla U; Coleman S; Dikiy S; Hata Y; Kurihara H; He JC; D'Agati VD; Klotman PE
    J Biol Chem; 2010 Aug; 285(33):25677-85. PubMed ID: 20562105
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Activation of NFAT signaling in podocytes causes glomerulosclerosis.
    Wang Y; Jarad G; Tripathi P; Pan M; Cunningham J; Martin DR; Liapis H; Miner JH; Chen F
    J Am Soc Nephrol; 2010 Oct; 21(10):1657-66. PubMed ID: 20651158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.